| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 62.858 | 29.465 | 17.727 | 0 |
| Total Income - EUR | - | - | - | 0 | 0 | 7.732 | 72.975 | 29.465 | 17.727 | 12.062 |
| Total Expenses - EUR | - | - | - | 0 | 1.728 | 32.690 | 42.886 | 50.691 | 48.612 | 31.431 |
| Gross Profit/Loss - EUR | - | - | - | 0 | -1.728 | -24.958 | 30.089 | -21.227 | -30.885 | -19.369 |
| Net Profit/Loss - EUR | - | - | - | 0 | -1.728 | -24.958 | 29.473 | -21.521 | -31.063 | -19.730 |
| Employees | - | - | - | 0 | 0 | 4 | 5 | 5 | 4 | 1 |
Check the financial reports for the company - Imunologic Pt Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 33.506 | 22.682 | 12.640 | 2.520 | 0 |
| Current Assets | - | - | - | 43 | 7 | 107 | 31.933 | 13.665 | 11.073 | 11.446 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 18.635 | 11.437 | 11.808 | 11.339 |
| Cash | - | - | - | 43 | 7 | 107 | 13.297 | 2.228 | -735 | 107 |
| Shareholders Funds | - | - | - | 43 | -1.686 | -26.611 | 3.452 | -18.059 | -49.067 | -46.002 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 0 | 1.693 | 26.718 | 28.517 | 21.648 | 40.013 | 57.448 |
| Income in Advance | - | - | - | 0 | 0 | 33.506 | 22.646 | 22.716 | 22.647 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Imunologic Pt Lab Srl